Clinical and metabolic profile of patients with latent autoimmune diabetes in adults in specialized care in Madrid.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Endocrinología Diabetes y Nutrición

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.endinu.2016.09.001PMID 28440768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Latent autoimmune diabetes in adults: are we paying sufficient attention?

  2015cited by this paper
• 2. Classification and Diagnosis of Diabetes

  2015cited by this paper
• Considerations in the Management of Gestational Diabetes Mellitus: “You Are What Your Mother Ate!”

  2015cited by this paper
• Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9

  2015cited by this paper
• High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).

  2014cited by this paper
• Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain

  2013cited by this paper
• Interventions for latent autoimmune diabetes (LADA) in adults.

  2011cited by this paper
• Genetic Similarities Between Latent Autoimmune Diabetes in Adults, Type 1 Diabetes, and Type 2 Diabetes

  2008cited by this paper
• An association analysis of the HLA gene region in latent autoimmune diabetes in adults

  2006cited by this paper
• [Latent autoimmune diabetes in adults].

  2006cited by this paper
• Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow.

  2006cited by this paper
• Latent autoimmune diabetes in adults.

  2006cited by this paper
• Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment.

  2005cited by this paper
• Latent autoimmune diabetes in adults (LADA) should be less latent

  2005cited by this paper
• Multicenter Prevention Trial of Slowly Progressive Type 1 Diabetes with Small Dose of Insulin (the Tokyo Study)

  2003cited by this paper
• Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

  1999cited by this paper
• Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies

  1996cited by this paper
• GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosis

  1995cited by this paper
• The Pathogenesis and Prevention of Diabetes in Adults: Genes, autoimmunity, and demography

  1995cited by this paper
• Islet Cell Antibodies Identify Latent Type I Diabetes in Patients Aged 35–75 Years at Diagnosis

  1986cited by this paper
• Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.

  1977cited by this paper

• Factors associated with Glycemia Risk Index in a cohort of patients with type 1 Diabetes Mellitus and Latent Autoimmune Diabetes In Adults (LADA)

  2024influential citation
• Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study

  2023cites this paper
• Body composition and sexual hormones for the glucose control of autoimmune diabetes in males: are they necessary to predict diabetes-related complications?

  2023cites this paper
• Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation

  2020cites this paper
• Prevalence of positive islet autoantibody in type 2 diabetes patients: a cross-sectional study in a Chinese community

  2019cites this paper
• Metabolic Characteristics of Recently Diagnosed Adult-Onset Autoimmune Diabetes Mellitus

  2018cites this paper